SCI时时刷

search
The coexistence of antiβ2 glycoprotein 1 antibody antibody has no effect on hemophilia A patient
The coexistence of antiβ2 glycoprotein 1 antibody antibody has no effect on hemophilia A patient
National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated H...
Molecular heterogeneity of factor XI deficiency in Tunisia
Molecular heterogeneity of factor XI deficiency in Tunisia
Factor XI (FXI) deficiency is a rare inherited bleeding disorder that is highly prevalent in Ashkena
A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency
A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency
The objective of the study was to analyse a novel F13A1 gene mutation in a Chinese patient with fact
Primary immune thrombocytopenia: a ‘diagnosis of exclusion’?
Primary immune thrombocytopenia: a ‘diagnosis of exclusion’?
Current diagnosis of primary immune thrombocytopenia (ITP) is presumptive, centered on excluding oth
Characterization of zebrafish gp1ba mutant and modelling Bernard Soulier syndrome
Characterization of zebrafish gp1ba mutant and modelling Bernard Soulier syndrome
The aim of this study is to model classical Bernard Soulier Syndrome in the zebrafish by targeting G
The role of thrombin in haemostasis
The role of thrombin in haemostasis
Thrombin is a multifunctional serine protease generated in injured cells. The generation of thrombin
The physiology of hemostasis
The physiology of hemostasis
The breakdown of vascular integrity triggers a series of reactions, initially involving a vasoconstr
Monitoring of new therapies for hemophilia
Monitoring of new therapies for hemophilia
Nonreplacement therapies, such as emicizumab (Hemlibra, Roche) and other myriad of molecules are sti
Evolutional development of the hemostasis laboratory and the treatment of hemophilia
Evolutional development of the hemostasis laboratory and the treatment of hemophilia
Department of Hematology, Vall d’Hebron University Hospital, Barcelona, Spain Correspondence to Vicente R. Co...
Microkinetic coagulation assays for human and zebrafish plasma
Microkinetic coagulation assays for human and zebrafish plasma
Coagulation assays, prothrombin time (PT), and partial thromboplastin time (PTT) are tests to measur
Evaluating the potential benefits of the extravascular pool of factor IX
Evaluating the potential benefits of the extravascular pool of factor IX
To the Editor, In practice, we evaluate the efficacy of haemostatic therapies through a combination of clinical...
Direct oral anticoagulant neutralization by activated charcoal DOAC-Remove for thrombophilia screening
Direct oral anticoagulant neutralization by activated charcoal DOAC-Remove for thrombophilia screening
aService de Biologie Médicale bService d’Hématologie, Centre Hospitalier de Versailles, Le Chesnay, France ...